ODTX peer analysis
Odyssey Therapeutics (ODTX) against its competitors: price, today's move, 1-year return and market value side by side.
ODTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.90 | 8.03% | 59.73% | $504.77M |
| AGMB AgomAb | $6.97 | 1.75% | – | – |
| ALMS Alumis | $6.03 | 3.08% | 31.51% | – |
| ANAB AnaptysBio | $45.80 | 0.48% | 29.08% | $1.39B |
| IMUX Immunic | $7.64 | 4.37% | 7.35% | $105.88M |
| ORKA Oruka Therapeutics | $103.90 | 8.21% | 276.35% | – |
| PTGX Protagonist Therapeutics | $132.04 | -2.38% | 69.22% | $8.53B |
| SYRE Spyre Therapeutics | $103.00 | 6.64% | 354.84% | – |
| ODTX Odyssey Therapeutics | $19.23 | 1.85% | – | – |
- ODTX's peers: ACRS (Aclaris Therapeutics), AGMB (AgomAb), ALMS (Alumis), ANAB (AnaptysBio), IMUX (Immunic), ORKA (Oruka Therapeutics), PTGX (Protagonist Therapeutics), SYRE (Spyre Therapeutics).
Updated 2026-11-08 03:46 UTC